Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06550674

Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma

Led by Centre Jean Perrin · Updated on 2026-03-19

50

Participants Needed

1

Research Sites

178 weeks

Total Duration

On this page

Sponsors

C

Centre Jean Perrin

Lead Sponsor

A

Association Nationale des Patients atteints de cancers de l'oeil (A.N.P.A.C.O.)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Only 20% of familial uveal melanomas are explained by a hereditary predisposition, implying the presence of as yet unknown hereditary predispositions. This hypothesis is reinforced by epidemiological studies revealing an excess risk of prostate cancer, thyroid cancer and leukemia in patients who have developed uveal melanoma, even though these cancers are not part of the tumor spectrum of known hereditary predispositions to uveal melanoma (BAP1, MBD4). The identification of new candidate genes, once validated, would enable us to offer these families appropriate surveillance.

CONDITIONS

Official Title

Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient with a personal history of uveal melanoma (newly diagnosed, under treatment or in follow-up)
  • Enrolled in or benefiting from a social security scheme
Not Eligible

You will not qualify if you...

  • Causal pathogenic variation identified in BAP1 or MBD4
  • Patient does not consent to constitutional genetic analysis for diagnostic purposes
  • Patient not consenting to a constitutional genetic analysis for research purposes
  • Pregnant and breast-feeding women
  • Patients under guardianship or trusteeship

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centre Jean PERRIN

Clermont-Ferrand, Puy-de-Dôme, France, 63011

Actively Recruiting

Loading map...

Research Team

A

Angeline GINZAC COUVÉ

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

PREVENTION

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here